Story at a glance
- The European Medicines Agency has not identified a risk factor linked to AstraZeneca’s vaccine and blood clotting.
- Multiple countries have restricted its use following concerns of adverse reactions.
A major health agency that oversees the safety and regulation of medicine in the European Union has not yet identified any risk factors such as age, sex or previous medical history that could be linked to blood clotting cases reported after receiving Astrazeneca’s COVID-19 vaccine.
The European Medicines Agency (EMA) said on Wednesday that the vaccine’s benefits outweigh the risks, but there is a remote possibility of rare blood clots occurring. The news comes amid recent reports that a small number of Astrazeneca vaccine recipients formed rare blood clots.
When studying the frequency of thromboembolic events in AstraZeneca vaccine recipients, however, EMA officials said that there is no evidence that the vaccine is associated with an increase in risks of blood clotting.
TRUMP’S CDC DIRECTOR MAKES SHOCKING STATEMENT ABOUT ORIGIN OF COVID-19 IN WUHAN LAB
EXTREMISTS ARE SPREADING APOCALYPTIC WARNINGS ABOUT COVID-19 VACCINES
PFIZER IS NOW TESTING A COVID-19 PILL
“These are rare cases – around 20 million people in the UK and EEA had received the vaccine as of March 16 and EMA had reviewed only 7 cases of blood clots in multiple blood vessels…and 18 cases of [Cerebral venous sinus thrombosis],” the statement read. “A causal link with the vaccine is not proven, but is possible and deserves further analysis.”
This comes as multiple countries, including Germany, France and Canada have all either completely halted or placed more restrictions on the usage of AstraZeneca as a COVID-19 vaccine option. Most recently, Germany suspended the use of AstraZeneca as a vaccine for residents under the age of 60.
AstraZeneca officials vehemently refute the allegations that the vaccine is unsafe.
Prior to these concerns, the vaccine had shown high rates of efficacy in preventing a COVID-19 infection in clinical trials. Multiple countries have authorized it for approval, with the U.S. being a notable exception.
Earlier in March, however, President Biden committed to sharing the U.S.’s allocated doses of AstraZeneca with its northern and southern neighbors, Canada and Mexico.
FAUCI SAYS NEW SURGE IN COVID-19 CASES HAS THREE MAIN CAUSES
TRUMP WHITE HOUSE CENSORED HEAD OF ITS OWN CORONAVIRUS TASK FORCE, NEW REPORT SAYS
THIS IS NOW THE WORST US STATE FOR COVID-19 INFECTIONS
TRUMP’S HEAD OF CORONAVIRUS TASK FORCE SAYS MOST COVID-19 DEATHS COULD HAVE BEEN PREVENTED
Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
